Patients with multiple sclerosis have higher levels of serum ghrelin

Berilgen M., Bulut S., Ustundag B., Tekatas A., Ayar A.

NEUROENDOCRINOLOGY LETTERS, vol.26, no.6, pp.819-822, 2005 (SCI-Expanded) identifier identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 26 Issue: 6
  • Publication Date: 2005
  • Journal Name: NEUROENDOCRINOLOGY LETTERS
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.819-822
  • Karadeniz Technical University Affiliated: No

Abstract

In addition to metabolic and neuroendocrine actions, the recently discovered hormone ghrelin has been found to have inhibitory effects on inflammatory processes. This novel finding suggests possible involvement of the peptide in the pathogenesis of inflammatory disorders including the inflammatory demyelinating disease of the central nervous system, multiple sclerosis (MS). The aim of the present study was to evaluate serum ghrelin levels in patients with MS.